Scroll Top
Emerging Markets Report
Image of Vinergy Capital logo.



Smart Minds, Smart Money | 09/27/2023 |

Vinergy Developing and Investing in the Next Generation of A.I. Driven Healthcare

Healthcare is always changing, evolving, endeavoring to be better for the patient and to be more profitable for the providers. In a perfect world, these separate needs align.

Rarely do they.

Today’s featured Company, Vinergy Capital Inc. (the “Company” or “Vinergy”) (CSE:VIN, OTCQB:VNNYF, FSE:1V7), has a plan for and is aggressively investing in what could be the next generation of ultra personalized and profitable healthcare designed to be a win/win for all involved.

Diverse group of patients sitting in waiting room at clinic.

Let’s start with the recognition that the healthcare experience for many Americans is wholly unsatisfying. Complaints range from misdiagnosis to horrible wait times. It can literally add insult to injury.

And the reality is that many patients are willing to pay a premium for better, more efficient care. Using concierge doctors or paying cash to see a preferred specialist out of your insurance’s plan are common choices. The market appetite is clear.

Enter into the equation the power of Artificial Intelligence which can dramatically enhance margins and the healthcare experience. That’s Vinergy’s core mission and the AI Healthcare market isn’t just clear, it’s enormous.

One recent research report by a firm completely unrelated to Vinergy projects that the “Worldwide Artificial Intelligence in Healthcare Market Size is expected to reach USD 280.77 Billion by 2032.”

(source link)

To this end, earlier this month Vinergy announced that it has a non-binding Letter of Intent (LOI) to acquire a 4% interest in a healthcare AI Platform (AIP) that has developed a cutting edge FDA and HIPAA compliant data and analysis platform specifically for drug development and laboratory applications. Better yet, the AIP is already generating revenue from its intellectual property and products with blue chip customers, which for us inspires some real confidence.

If the Company is already earning, then the tech is proven in the marketplace. If it’s proven by blue chip customers, well then, that’s an order of magnitude more confidence inspiring.

Too often we see great ideas sold as earners that are still in a nascent, beta, or concept state especially in white-hot markets like A.I.

Not here.

And it doesn’t hurt that we had all this explained to us by a veteran healthcare executive and Yale lecturer who has come on board at Vinergy and has been appointed to the investment committee of the Company and will act as its Chair.


If the LOI consummates, and it’s a reasonable expectation that it will, it will add to a compelling AI/HealthCare portfolio that recently added another A.I. significant piece vis-à-vis purchasing nearly half of Healthcare Accretion Group which was founded by a diverse assemblage of professionals with backgrounds that include elite institutions like Yale/New Haven Hospital, Harvard, Cornell and more. This team has come together in this unique time to lever the quickly burgeoning potential of artificial intelligence and machine learning to healthcare services market.

Again, Vinergy and its shareholders own 49% of the Company now.

We intend to publish more going forward about the Company’s plans to use AI to change outcomes for patients and providers as more develops.

But right now we wanted to make a first introduction to a Company full of smart minds looking to put smart money into one of the deepest verticals on the planet.

Close up of businessman hands holding tablet with abstract glowing blue circuit dollar hologram.

About The Emerging Markets Report:
The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

Must Read OTC Markets/SEC policy on stock promotion and investor protection

Don’t Miss Our Email Updates:

Add [email protected] to your email favorites.

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.


EMC has been paid $90,000 by Vinergy Capital Inc. EMC does not independently verify any of the content linked-to from this editorial. | Please read our full disclaimer.

Subscribe to our newsletter for must read alerts.

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.